Meeting the 2024 deadline for an international agreement on pandemic response may not happen; the Biden administration announces measures to counter restrictive state laws on abortion; cervical cancer incidence declines as more women receive the human papillomavirus vaccine.
Concerns Over Impending Deadline for Global Pandemic Accord
Director-general of the World Health Organization, Tedros Adhanom Ghebreyesus, PhD, MSc, is voicing apprehension regarding the approaching deadline for a global pandemic accord, according to Reuters. Additionally, he emphasizes the complexities involved in reaching a consensus on an international framework for pandemic response in 2024. This new pact and a series of updates to existing rules pertaining to pandemics are intended to be a comprehensive international agreement to shore up the world’s defenses against new pathogens after the COVID-19 pandemic.
Biden Administration Unveils New Abortion Initiatives on Roe v Wade Anniversary
On the anniversary of the Roe v Wade decision, the Biden administration has introduced a series of new initiatives aimed at supporting and protecting abortion rights, according to NBC News. President Biden's announcement came in response to the increasing challenges posed by restrictive state laws, reaffirming the administration's commitment to upholding reproductive rights. The initiatives signal a proactive approach to safeguarding access to abortion services and addressing the ongoing legal battles surrounding reproductive health care.
Cervical Cancer Increasing in Women Despite HPV Vaccine
New research suggests a positive correlation between the widespread administration of the human papillomavirus (HPV) vaccine and a significant decrease in cervical cancer cases among women, with rates falling fastest in women in their 20s, according to NBC News. However, cervical cancer incidence has been increasing in women in their 30s and early 40s, suggesting that not all women are similarly benefitting. As more individuals receive the vaccine, this development underscores the potential for further progress in preventing cervical cancer and related health complications.
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Neurologists Share Tips for Securing Patient Access to Gene Therapies
March 19th 2025Tenacious efforts at every level, from the individual clinician to the hospital to the state to Congress, will be needed to make sure patients can access life-saving gene therapies for neuromuscular diseases.
Read More